Cancer
FDA approves Eisai breast cancer drug Halaven
November 16, 2010Sales and Marketing Cancer, Eisai, FDA, Halaven, Xeloda, breast cancer, eribulin mesylate, metastatic breast cancer
The FDA has approved Eisai’s advanced breast cancer drug Halaven for use in heavily pre-treated breast cancer patients. Halaven (eribulin …
Quarter of all cancers found at late stage
November 15, 2010Cancer, England, NCIN, NHS, National Cancer Intelligence Network, brain cancer, cancer diagnosis, leukaemia
Nearly a quarter of all cancer diagnoses in England came after a patient had been admitted to hospital for emergency …
NICE limits access to cancer drugs, study confirms
November 10, 2010Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Cancer Drugs Fund, IPSOR, Maximilian Lebmeier, NICE, hta
NICE became more restrictive in its assessment of new cancer drugs between 2007 and 2009, a new report suggests. The …
Roche’s melanoma candidate impresses in phase II trials
November 5, 2010Research and Development BRAF protein, Cancer, Phase II, Plexxikon, RG7204, Roche
Roche’s mid-stage melanoma candidate has produced positive results in a difficult to treat cancer. RG7204 is an investigational, first-in-class molecule …
£600m confirmed for three year Cancer Drugs Fund
October 27, 2010Sales and Marketing Cancer, Cancer Drugs Fund, NHS, NICE, cancer drugs, value-based pricing
The NHS will get the extra money it was promised to improve patient access to cancer medicines not backed by …
Cutting-edge cancer treatments showcased at ESMO
October 18, 2010Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine
The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …
Treasure trove of cancer information on tap for GPs
October 11, 2010Medical Communications Cancer, Doctors.net.uk, GP, cancer care, online community, professional network
Cancer Research UK appoints Doctors.net to launch campaign to raise awareness of the charity’s vast information resources for GPs
Uncertainty over new cancer fund
October 6, 2010Sales and Marketing Cancer, NHS, government
The UK government has launched its £50 million interim fund to give greater access to new cancer medicines. The new …
ASCO 2010: The Hedgehog Pathway and other ways to target cancer
August 19, 2010Research and Development ASCO, Cancer, thyroid cancer
The American Society of Clinical Oncology conference, one of the most important dates in the pharmaceutical industry’s calendar, took place …
UK lags behind Europe on innovative cancer drugs
July 29, 2010Sales and Marketing Cancer, market access
The UK has been ranked as one of the worst countries when it comes to uptake of new cancer drug …
Lansley to create £50 million cancer drugs fund
July 28, 2010Sales and Marketing Cancer, NHS, government, market access
The UK government is setting up a multi-million pound fund dedicated to improving patient access to innovative new cancer drugs. …
New measures to help patients with mystery cancers
July 27, 2010CUP, Cancer, NHS, NICE
Patients whose cancer has spread to other parts of the body from an unknown primary location are to be given …
Study boost for personalised cancer treatments
July 23, 2010Research and Development Cancer, genome, genomics, personalised medicine
A five-year study by scientists in the UK and US of the way genomes and cancer medicines interact has yielded …
NICE rejects Takeda cancer drug over price concerns
July 12, 2010Sales and Marketing Cancer, Mepact, NICE, Takeda, bone cancer
UK cost-effectiveness watchdog NICE has rejected Takeda’s orphan bone cancer drug Mepact due to concerns over price. In its draft …
Bayer signs cancer stem cell research deal
June 18, 2010Research and Development Bayer Schering Pharma, Cancer, OncoMed, Stem cells
Bayer Schering Pharma has teamed up with a US oncology specialist to develop novel antibodies, protein therapeutics and small molecules …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
